Maini CL - Search Results

1

Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.

Lopez M, Vici P, Di Lauro K, Conti F, Paoletti G, Ferraironi A, Sciuto R, Giannarelli D, Maini CL. Lopez M, et al. Among authors: maini cl. J Clin Oncol. 1998 Jan;16(1):86-92. doi: 10.1200/JCO.1998.16.1.86. J Clin Oncol. 1998. PMID: 9440727 Clinical Trial.

2

Cardiotoxicity of high-dose-rate epirubicin evaluated by angiocardioscintigraphy.

Maini C, Perraironi A, Sciuto R, Vici P, Tofani A, Conti F, Lopez M. Maini C, et al. Oncol Rep. 1995 May;2(3):443-6. doi: 10.3892/or.2.3.443. Oncol Rep. 1995. PMID: 21597755

3

Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.

Maini CL, Tofani A, Sciuto R, Semprebene A, Cavaliere R, Mottolese M, Benevolo M, Ferranti F, Grandinetti ML, Vici P, Lopez M, Botti C. Maini CL, et al. J Nucl Med. 1997 Oct;38(10):1546-51. J Nucl Med. 1997. PMID: 9379190 Free article.

4

Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.

Maini CL, Sciuto R, Ferraironi A, Vici P, Tofani A, Festa A, Conti F, Lopez M. Maini CL, et al. J Nucl Cardiol. 1997 Nov-Dec;4(6):502-8. doi: 10.1016/s1071-3581(97)90008-8. J Nucl Cardiol. 1997. PMID: 9456190

5

Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.

Vici P, Ferraironi A, Di Lauro L, Carpano S, Conti F, Belli F, Paoletti G, Maini CL, Lopez M. Vici P, et al. Among authors: maini cl. Clin Ter. 1998 Jan-Feb;149(921):15-20. Clin Ter. 1998. PMID: 9621483 Review.

6

Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.

Sciuto R, Festa A, Rea S, Pasqualoni R, Bergomi S, Petrilli G, Maini CL. Sciuto R, et al. Among authors: maini cl. J Nucl Med. 2002 Jan;43(1):79-86. J Nucl Med. 2002. PMID: 11801708 Free article. Clinical Trial.

7

Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.

Sciuto R, Pasqualoni R, Bergomi S, Petrilli G, Vici P, Belli F, Botti C, Mottolese M, Maini CL. Sciuto R, et al. Among authors: maini cl. J Nucl Med. 2002 Jun;43(6):745-51. J Nucl Med. 2002. PMID: 12050317 Free article. Clinical Trial.

8

Thallium-201 scintigraphy and chemotherapeutic response in rhabdomyosarcoma.

Maini CL, Tofani A, Sciuto R, Carpano S, Crecco M, Manni C, Lopez M. Maini CL, et al. Clin Nucl Med. 1994 Jul;19(7):607-10. doi: 10.1097/00003072-199407000-00010. Clin Nucl Med. 1994. PMID: 7924102

9

TSH suppression by octreotide in differentiated thyroid carcinoma.

Maini CL, Sciuto R, Tofani A. Maini CL, et al. Clin Endocrinol (Oxf). 1994 Mar;40(3):335-9. doi: 10.1111/j.1365-2265.1994.tb03928.x. Clin Endocrinol (Oxf). 1994. PMID: 8187297 Clinical Trial.

10

111In-octreotide scintigraphy in small cell lung cancer.

Semprebene A, Ferraironi A, Franciotti G, Venturo I, Giunta S, Lopez M, Maini CL. Semprebene A, et al. Among authors: maini cl. Q J Nucl Med. 1995 Dec;39(4 Suppl 1):108-10. Q J Nucl Med. 1995. PMID: 9002764

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters